reports hero background
UPDATED: Nov 13, 2025

Stock Analysis

$0.28
-$0.02 |-5.84%
Day Range:
$0.28 - $0.29
Market Cap:
9.89M
P/E Ratio:
0.0000
Avg Value:
$20.87
Year Range:
$0.25 - $41.49
1
General Information
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions.

Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.

2
Park Ha Biological Tech (BYAH) Stock Graph
3
How We Grade Park Ha Biological Tech (BYAH)

We grade stocks based on past performance, their future growth potential, intrinsic value, dividend history, and overall financial health.

The chart below shows how we grade Park Ha Biological Tech (BYAH) across the board compared to its closest peers.

4
Benzinga Edge Rankings

Benzinga Edge stock rankings give you four critical scores to help you identify the strongest and weakest stocks to buy and sell.

5
Peer Ratings

See how Park Ha Biological Tech compares to its peers in these key performance metrics from Benzinga Rankings.

Top Peers
Value
Quality
Growth
Momentum
Short
Medium
Long
TKLFTokyo Lifestyle Co
98.23
0
54.34
18.45
JWELJowell Global
0
0
17.39
17.14
FTELFitell
0
0
0
0.47
LESLLeslies
11.1
0
11.92
0.1
Short: price trend over the last couple of months
Medium: price trend over the last couple of quarters
Long: price trend over the past year
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
6
Past Performance
How has Park Ha Biological Tech (BYAH) performed over the past 5 years?

The two main factors that we consider when analyzing past performance is overall return and volatility

Using these two metrics, we can determine if this stock gave its investors enough return for the risk that they took on by owning it. This is measured by the sharpe ratio, which has been used as a primary measure of risk/reward trade-off for almost 60 years.

This ratio can be interpreted as the amount of return an investor has received for the amount of risk that they took on by owning the stock over that timeframe.

Park Ha Biological Tech (BYAH) sharpe ratio over the past 5 years is -0.1340 which is considered to be above average compared to the peer average of -0.1823